Cat. No.: DIA-0231289
Product Information | |
---|---|
CAS No. | 237430-03-4 |
Chemical Name | 7,12-Dihydro-9-nitroindolo[3,2-d][1]benzazepin-6(5H)-one |
Formula | C16H11N3O3 |
Molecular Weight | 293.28 |
PubChem CID | 5005498 |
SMILES | [O-][N+](=O)c4cc3c(NC1C3CC(=O)Nc2ccccc12)cc4 |
Target | CDK and GSK-3β |
Product Description | Potent cyclin-dependent kinase (CDK) and GSK-3β inhibitor |
Format & Storage | |
---|---|
Format | Solid |
Purity | > 96% |
Source | Synthetic |
Shipping | Shipped on dry ice. |
Storage | Store at +4 °C. Store under desiccating conditions. The product can be stored for up to 12 months. |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.